Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
95% CI | P | 95% CI | P | |
Overall survival | ||||
Age | 0.99–1.04 | 0.4 | 0.98–2.90 | 0.009 |
Lymph node status (+/-) | 2.79–153.9 | 0.004 | 2.65–161 | 0.003 |
Invasive tumour grade (I, II, II) | 1.27–4.93 | 0.002 | 1.14–4.62 | 0.002 |
Tumour size (cm) | 1.02–1.05 | <0.001 | 1.02–1.05 | <0.001 |
NPI | 1.48–3.36 | <0.001 | 1.39–3.32 | <0.001 |
ER quick-score | 0.66–0.92 | 0.002 | 0.68–0.98 | 0.03 |
HER-2 score | 0.94–2.02 | 0.04 | 0.76–1.95 | 0.56 |
Ki67 proliferative index | 0.99–1.00 | 0.4 | 0.99–1.00 | 0.65 |
Lymphovascular invasion (+/-) | 1.46–9.38 | 0.006 | 0.89–6.69 | 0.08 |
Hdm2 cytoplasm MQS | 0.66–0.95 | 0.01 | 0.67–0.97 | 0.02 |
Hdm2 nucleus MQS | 0.68–1.01 | 0.07 | 0.69–1.05 | 0.13 |
Disease-free survival | ||||
Age | 0.97–1.02 | 0.9 | 0.99–1.06 | 0.06 |
Lymph node status (+/-) | 2.29–25.3 | <0.001 | 2.06–25.6 | 0.002 |
Invasive tumour grade (I, II, II) | 1.48–5.38 | 0.005 | 1.36–5.11 | 0.006 |
Tumour size (cm) | 1.02–1.04 | <0.001 | 1.02–1.04 | <0.001 |
NPI | 1.46–3.17 | <0.001 | 1.38–3.15 | <0.001 |
ER quick-score | 0.66–0.89 | 0.001 | 0.68–0.95 | 0.01 |
HER-2 score | 1.04–1.92 | 0.02 | 0.95–1.87 | 0.2 |
Ki67 Proliferative index | 0.99–1.00 | 0.2 | 0.99–1.00 | 0.3 |
Lymphovascular invasion (+/-) | 1.63–6.95 | 0.002 | 1.09–6.65 | 0.03 |
Hdm2 cytoplasm MQS | 0.73–1.02 | 0.05 | 0.70–0.98 | 0.03 |
Hdm2 nucleus MQS | 0.78–1.09 | 0.34 | 0.76–1.09 | 0.9 |